A new MAP-kinase inhibitor, CNI-1493, is safe and effective in the treatment of moderate to severe Crohn's disease

✍ Scribed by Hommes, Daniel W.; van den Blink, Bernt; van de Heisteeg, Brenda; Plasse, Terry; de Ley, Maartje; Macpherson, Bret; Bartelsman, Joep F.W.; Van Deventer, Sander J.H.

• Book ID: 124136379
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 178 KB
• Volume: 120
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(08)82244-5